Chapter/Section Purchase

1 Study Coverage
1.1 Primary Hyperoxaluria Drug Product Introduction
1.2 Market by Type
1.2.1 Global Primary Hyperoxaluria Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 ALLN-230
1.2.3 DCR-PHXC
1.2.4 ALN-GO1
1.2.5 Others
1.3 Market by Application
1.3.1 Global Primary Hyperoxaluria Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Primary Hyperoxaluria Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Primary Hyperoxaluria Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Primary Hyperoxaluria Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Primary Hyperoxaluria Drug Sales by Region
2.4.1 Global Primary Hyperoxaluria Drug Sales by Region (2017-2022)
2.4.2 Global Sales Primary Hyperoxaluria Drug by Region (2023-2028)
2.5 Global Primary Hyperoxaluria Drug Revenue by Region
2.5.1 Global Primary Hyperoxaluria Drug Revenue by Region (2017-2022)
2.5.2 Global Primary Hyperoxaluria Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Primary Hyperoxaluria Drug Sales by Manufacturers
3.1.1 Global Top Primary Hyperoxaluria Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Primary Hyperoxaluria Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Primary Hyperoxaluria Drug in 2021
3.2 Global Primary Hyperoxaluria Drug Revenue by Manufacturers
3.2.1 Global Primary Hyperoxaluria Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Primary Hyperoxaluria Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Primary Hyperoxaluria Drug Revenue in 2021
3.3 Global Primary Hyperoxaluria Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Primary Hyperoxaluria Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Primary Hyperoxaluria Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Primary Hyperoxaluria Drug Sales by Type
4.1.1 Global Primary Hyperoxaluria Drug Historical Sales by Type (2017-2022)
4.1.2 Global Primary Hyperoxaluria Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Primary Hyperoxaluria Drug Sales Market Share by Type (2017-2028)
4.2 Global Primary Hyperoxaluria Drug Revenue by Type
4.2.1 Global Primary Hyperoxaluria Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Primary Hyperoxaluria Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Primary Hyperoxaluria Drug Revenue Market Share by Type (2017-2028)
4.3 Global Primary Hyperoxaluria Drug Price by Type
4.3.1 Global Primary Hyperoxaluria Drug Price by Type (2017-2022)
4.3.2 Global Primary Hyperoxaluria Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Primary Hyperoxaluria Drug Sales by Application
5.1.1 Global Primary Hyperoxaluria Drug Historical Sales by Application (2017-2022)
5.1.2 Global Primary Hyperoxaluria Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Primary Hyperoxaluria Drug Sales Market Share by Application (2017-2028)
5.2 Global Primary Hyperoxaluria Drug Revenue by Application
5.2.1 Global Primary Hyperoxaluria Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Primary Hyperoxaluria Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Primary Hyperoxaluria Drug Revenue Market Share by Application (2017-2028)
5.3 Global Primary Hyperoxaluria Drug Price by Application
5.3.1 Global Primary Hyperoxaluria Drug Price by Application (2017-2022)
5.3.2 Global Primary Hyperoxaluria Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Primary Hyperoxaluria Drug Market Size by Type
6.1.1 North America Primary Hyperoxaluria Drug Sales by Type (2017-2028)
6.1.2 North America Primary Hyperoxaluria Drug Revenue by Type (2017-2028)
6.2 North America Primary Hyperoxaluria Drug Market Size by Application
6.2.1 North America Primary Hyperoxaluria Drug Sales by Application (2017-2028)
6.2.2 North America Primary Hyperoxaluria Drug Revenue by Application (2017-2028)
6.3 North America Primary Hyperoxaluria Drug Market Size by Country
6.3.1 North America Primary Hyperoxaluria Drug Sales by Country (2017-2028)
6.3.2 North America Primary Hyperoxaluria Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Primary Hyperoxaluria Drug Market Size by Type
7.1.1 Europe Primary Hyperoxaluria Drug Sales by Type (2017-2028)
7.1.2 Europe Primary Hyperoxaluria Drug Revenue by Type (2017-2028)
7.2 Europe Primary Hyperoxaluria Drug Market Size by Application
7.2.1 Europe Primary Hyperoxaluria Drug Sales by Application (2017-2028)
7.2.2 Europe Primary Hyperoxaluria Drug Revenue by Application (2017-2028)
7.3 Europe Primary Hyperoxaluria Drug Market Size by Country
7.3.1 Europe Primary Hyperoxaluria Drug Sales by Country (2017-2028)
7.3.2 Europe Primary Hyperoxaluria Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Primary Hyperoxaluria Drug Market Size by Type
8.1.1 Asia Pacific Primary Hyperoxaluria Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Primary Hyperoxaluria Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Primary Hyperoxaluria Drug Market Size by Application
8.2.1 Asia Pacific Primary Hyperoxaluria Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Primary Hyperoxaluria Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Primary Hyperoxaluria Drug Market Size by Region
8.3.1 Asia Pacific Primary Hyperoxaluria Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Primary Hyperoxaluria Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Primary Hyperoxaluria Drug Market Size by Type
9.1.1 Latin America Primary Hyperoxaluria Drug Sales by Type (2017-2028)
9.1.2 Latin America Primary Hyperoxaluria Drug Revenue by Type (2017-2028)
9.2 Latin America Primary Hyperoxaluria Drug Market Size by Application
9.2.1 Latin America Primary Hyperoxaluria Drug Sales by Application (2017-2028)
9.2.2 Latin America Primary Hyperoxaluria Drug Revenue by Application (2017-2028)
9.3 Latin America Primary Hyperoxaluria Drug Market Size by Country
9.3.1 Latin America Primary Hyperoxaluria Drug Sales by Country (2017-2028)
9.3.2 Latin America Primary Hyperoxaluria Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Primary Hyperoxaluria Drug Market Size by Type
10.1.1 Middle East and Africa Primary Hyperoxaluria Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Primary Hyperoxaluria Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Primary Hyperoxaluria Drug Market Size by Application
10.2.1 Middle East and Africa Primary Hyperoxaluria Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Primary Hyperoxaluria Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Primary Hyperoxaluria Drug Market Size by Country
10.3.1 Middle East and Africa Primary Hyperoxaluria Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Primary Hyperoxaluria Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Allena Pharmaceuticals Inc
11.1.1 Allena Pharmaceuticals Inc Corporation Information
11.1.2 Allena Pharmaceuticals Inc Overview
11.1.3 Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Allena Pharmaceuticals Inc Recent Developments
11.2 Alnylam Pharmaceuticals Inc
11.2.1 Alnylam Pharmaceuticals Inc Corporation Information
11.2.2 Alnylam Pharmaceuticals Inc Overview
11.2.3 Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Alnylam Pharmaceuticals Inc Recent Developments
11.3 Dicerna Pharmaceuticals Inc
11.3.1 Dicerna Pharmaceuticals Inc Corporation Information
11.3.2 Dicerna Pharmaceuticals Inc Overview
11.3.3 Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Dicerna Pharmaceuticals Inc Recent Developments
11.4 Intellia Therapeutics Inc
11.4.1 Intellia Therapeutics Inc Corporation Information
11.4.2 Intellia Therapeutics Inc Overview
11.4.3 Intellia Therapeutics Inc Primary Hyperoxaluria Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Intellia Therapeutics Inc Primary Hyperoxaluria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Intellia Therapeutics Inc Recent Developments
11.5 OxThera AB
11.5.1 OxThera AB Corporation Information
11.5.2 OxThera AB Overview
11.5.3 OxThera AB Primary Hyperoxaluria Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 OxThera AB Primary Hyperoxaluria Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 OxThera AB Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Primary Hyperoxaluria Drug Industry Chain Analysis
12.2 Primary Hyperoxaluria Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Primary Hyperoxaluria Drug Production Mode & Process
12.4 Primary Hyperoxaluria Drug Sales and Marketing
12.4.1 Primary Hyperoxaluria Drug Sales Channels
12.4.2 Primary Hyperoxaluria Drug Distributors
12.5 Primary Hyperoxaluria Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Primary Hyperoxaluria Drug Industry Trends
13.2 Primary Hyperoxaluria Drug Market Drivers
13.3 Primary Hyperoxaluria Drug Market Challenges
13.4 Primary Hyperoxaluria Drug Market Restraints
14 Key Findings in The Global Primary Hyperoxaluria Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer